Corporate
WSAU / Reuters
Bloomberg Law
InfoMoney
3 outlets
Saturday, September 12, 2026

OpenAI delays IPO to 2027 citing mounting AI safety risks

Source: WSAU / Reuters
Read original|NVDA $218.29ORCL $150.28

TL;DR

AI-Summarizedfrom 3 sources

On September 12, 2026, Reuters reported that OpenAI CEO Sam Altman told Fortune the company will not go public in 2026 and is instead looking at a potential 2027 listing. Altman said an IPO this year would be ill advised given AI safety concerns and referenced non trivial extinction risks and recent rogue agent incidents. Follow up coverage in financial media and international outlets confirmed the delay and tied it to OpenAI’s trillion dollar valuation ambitions and parallel Anthropic IPO plans.

About this summary

This article aggregates reporting from 3 news sources. The TL;DR is AI-generated from original reporting. Race to AGI's analysis provides editorial context on implications for AGI development.

3 sources covering this story|5 companies mentioned

Race to AGI Analysis

OpenAI deciding to push its IPO to 2027 is less about capital scarcity and more about political timing. The company has already tapped enormous private financing, including structured deals with SoftBank and Microsoft, so staying private another year does not fundamentally change how much compute it can buy. What it does change is the scrutiny profile. Remaining off the public markets gives OpenAI a bit more room to negotiate safety commitments, respond to incidents like the Hugging Face breach, and align with Anthropic’s “pacing the frontier” push without quarterly earnings pressure.

Strategically, tying the delay explicitly to safety is noteworthy. Altman is telling regulators and the public that OpenAI will subordinate near term liquidity to managing extinction level risks, even if critics question how sincere that is. At the same time, the messaging keeps OpenAI in the same narrative frame as Anthropic’s impending IPO, which is expected to land at a similarly astronomical valuation. Both firms are signaling that they intend to be long lived, systemically important infrastructure players, not just high growth startups.

From a race to AGI perspective, the IPO timing itself is largely neutral. Training runs at this scale are financed years ahead through private and vendor deals. The more interesting development is Altman hinting at a cross lab slowdown agreement in the same breath that he rules out a 2026 listing. If that pact materializes, it could matter far more to the AGI timeline than whether OpenAI rings a bell on Wall Street in 2026 or 2027.

Who Should Care

InvestorsResearchersEngineersPolicymakers

Companies Mentioned

OpenAI
OpenAI
AI Lab|United States
Valuation: $840.0B
Anthropic
Anthropic
AI Lab|United States
Valuation: $965.0B
Nvidia
Nvidia
Chipmaker|United States
Valuation: $5100.0B
NVDANASDAQ$218.29
Oracle
Oracle
Cloud|United States
Valuation: $425.6B
ORCLNYSE$150.28
SoftBank
SoftBank
VC Firm|Japan
Valuation: $210.3B

Coverage Sources

WSAU / Reuters
Bloomberg Law
InfoMoney
WSAU / Reuters
WSAU / Reuters
Read
Bloomberg Law
Bloomberg Law
Read
InfoMoney
InfoMoneyPT
Read